|
IRS Rule Defines Orphan Drugs In Context of ACA Tax
Sales of orphan drugs are excluded under a proposed IRS rule that creates a new tax on pharmaceutical companies, but the definition of an orphan drug in the draft rule runs counter to what industry had wanted.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives